000 01247 a2200349 4500
005 20250518000720.0
264 0 _c20190325
008 201903s 0 0 eng d
022 _a1537-2995
024 7 _a10.1111/trf.14841
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMacIsaac, John
245 0 0 _aSystematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin.
_h[electronic resource]
260 _bTransfusion
_c11 2018
300 _a2729-2735 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Systematic Review
650 0 4 _aAntirheumatic Agents
_xtherapeutic use
650 0 4 _aAutoimmune Diseases
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aImmunoglobulins, Intravenous
_xtherapeutic use
650 0 4 _aRituximab
_xtherapeutic use
700 1 _aSiddiqui, Reda
700 1 _aJamula, Erin
700 1 _aLi, Na
700 1 _aBaker, Steven
700 1 _aWebert, Kathryn E
700 1 _aEvanovitch, Denise
700 1 _aHeddle, Nancy M
700 1 _aArnold, Donald M
773 0 _tTransfusion
_gvol. 58
_gno. 11
_gp. 2729-2735
856 4 0 _uhttps://doi.org/10.1111/trf.14841
_zAvailable from publisher's website
999 _c28864127
_d28864127